Interphase Cytogenetics in Breast Tumors P53 Gene Alterations
Abstract
HE PURPOSE OF THIS RESEARCH IS TO COMPARE NUMERICAL CHROMOSOME ABERRATIONS AND P53 GENE ALTERATIONS IN 250 NODE-NEGATIVE BREAST CANCERS TO 250 NON-POSITIVE BREAST CANCERS AND THEIR SURVIVAL. SCOPE: Interphase cytogenetics will be performed in paraffin sections utilizing biotinylated probes specific for centromeric regions of chromosomes 1, 8, 11, 13, 17, 18, and X. Chromosome profiles based on 300 tumor cells will be generated for each patient.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 1993
- Accession Number
- ADA341896
Entities
People
- Isabell A. Sesterhenn
Organizations
- Armed Forces Institute of Pathology